Androgen Therapy for Patients With Lower-Risk Myelodysplastic Syndrome and Significant Cytopenia: A Retrospective Study

British Journal of Haematology- United Kingdom

doi 10.1111/bjh.16121

Full Text

Abstract

Available in

Categories

Date

August 1, 2019

Authors

Han‐Seung Park

Young‐Shin Lee

Young‐Ah Kang

Kyoo‐Hyung Lee

Publisher

Wiley

Related search

A Retrospective Evaluation of Patients With Myelodysplastic Syndrome

Experimental Biomedical Research

English

Long-Term Outcome of Immunosuppressive Therapy for Japanese Patients With Lower-Risk Myelodysplastic Syndromes

International Journal of Hematology

English

Clinical Efficacy of Chelation Therapy in Patients With Low-Risk Myelodysplastic Syndrome

Klinicheskaya Onkogematologiya/Clinical Oncohematology

English

A Nationwide Survey of Hypoplastic Myelodysplastic Syndrome (A Multicenter Retrospective Study)

American Journal of Hematology

English

Association Between Ischaemic Bowel Syndromes and Androgen Deprivation Therapy in Patients With Prostate Cancer: A Retrospective Cohort Study

English

Prognostic Markers of Efficiency of Immunosupressive Therapy in Patients With Myelodysplastic Syndrome

English

Is Neoadjuvant Androgen Deprivation Therapy Necessary for Patients With Intermediate-Risk Prostate Cancer Treated With Proton Therapy?

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes

Journal of Clinical Oncology

Cancer Research

English

Hemophagocytic Syndrome in Patients With Unexplained Cytopenia: Report of 15 Cases

Turk Patoloji Dergisi

Forensic Medicine

English